Informação sobre produto
ASP2905 is a drug candidate that has been shown to attenuate the symptoms of Alzheimer's disease in mice. It is an orally active compound that binds to the virus's RNA and prevents it from replicating. ASP2905 also inhibits the production of amyloid beta, which are proteins that are believed to be responsible for the development of Alzheimer's disease. ASP2905 has been found to be effective against neuropharmacological disorders in neonatal mice, such as hyperlocomotion. The drug was also found to be effective at mitigating the effects of Parkinson's disease in knockout mice when administered at an effective dose.
Propriedades químicas
Consulta técnica sobre: 3D-SGB18490 ASP2905
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
